Imiquimod enhances excitability of dorsal root ganglion neurons by inhibiting background (K(2P)) and voltage-gated (K(v)1.1 and K(v)1.2) potassium channels
- PMID: 22233604
- PMCID: PMC3292985
- DOI: 10.1186/1744-8069-8-2
Imiquimod enhances excitability of dorsal root ganglion neurons by inhibiting background (K(2P)) and voltage-gated (K(v)1.1 and K(v)1.2) potassium channels
Abstract
Background: Imiquimod (IQ) is known as an agonist of Toll-like receptor 7 (TLR7) and is widely used to treat various infectious skin diseases. However, it causes severe itching sensation as its side effect. The precise mechanism of how IQ causes itching sensation is unknown. A recent report suggested a molecular target of IQ as TLR7 expressed in dorsal root ganglion (DRG) neurons. However, we recently proposed a TLR7-independent mechanism, in which the activation of TLR7 is not required for the action of IQ in DRG neurons. To resolve this controversy regarding the involvement of TLR7 and to address the exact molecular identity of itching sensation by IQ, we investigated the possible molecular target of IQ in DRG neurons.
Findings: When IQ was applied to DRG neurons, we observed an increase in action potential (AP) duration and membrane resistance both in wild type and TLR7-deficient mice. Based on these results, we tested whether the treatment of IQ has an effect on the activity of K(+) channels, K(v)1.1 and K(v)1.2 (voltage-gated K(+) channels) and TREK1 and TRAAK (K(2P) channels). IQ effectively reduced the currents mediated by both K(+) channels in a dose-dependent manner, acting as an antagonist at TREK1 and TRAAK and as a partial antagonist at K(v)1.1 and K(v)1.2.
Conclusions: Our results demonstrate that IQ blocks the voltage-gated K(+) channels to increase AP duration and K(2P) channels to increase membrane resistance, which are critical for the membrane excitability of DRG neurons. Therefore, we propose that IQ enhances the excitability of DRG neurons by blocking multiple potassium channels and causing pruritus.
Figures



Similar articles
-
TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons.Am J Physiol Cell Physiol. 2006 Jul;291(1):C138-46. doi: 10.1152/ajpcell.00629.2005. Epub 2006 Feb 22. Am J Physiol Cell Physiol. 2006. PMID: 16495368
-
Characterization of temperature-sensitive leak K+ currents and expression of TRAAK, TREK-1, and TREK2 channels in dorsal root ganglion neurons of rats.Mol Brain. 2018 Jul 6;11(1):40. doi: 10.1186/s13041-018-0384-5. Mol Brain. 2018. PMID: 29980241 Free PMC article.
-
Single voltage-gated K+ channels and their functions in small dorsal root ganglion neurones of rat.J Physiol. 1996 Jun 1;493 ( Pt 2)(Pt 2):393-408. doi: 10.1113/jphysiol.1996.sp021391. J Physiol. 1996. PMID: 8782104 Free PMC article.
-
Gating the pore of potassium leak channels.Eur Biophys J. 2009 Dec;39(1):61-73. doi: 10.1007/s00249-009-0457-6. Epub 2009 Apr 29. Eur Biophys J. 2009. PMID: 19404634 Review.
-
The role of K₂p channels in anaesthesia and sleep.Pflugers Arch. 2015 May;467(5):907-16. doi: 10.1007/s00424-014-1654-4. Epub 2014 Dec 9. Pflugers Arch. 2015. PMID: 25482669 Free PMC article. Review.
Cited by
-
Neural processing of itch.Neuroscience. 2013 Oct 10;250:697-714. doi: 10.1016/j.neuroscience.2013.07.035. Epub 2013 Jul 24. Neuroscience. 2013. PMID: 23891755 Free PMC article. Review.
-
Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk.Front Pharmacol. 2022 Mar 7;13:745658. doi: 10.3389/fphar.2022.745658. eCollection 2022. Front Pharmacol. 2022. PMID: 35321329 Free PMC article. Review.
-
Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain.Pflugers Arch. 2015 May;467(5):931-43. doi: 10.1007/s00424-014-1655-3. Epub 2014 Nov 26. Pflugers Arch. 2015. PMID: 25420526 Review.
-
TLR7 negatively regulates dendrite outgrowth through the Myd88-c-Fos-IL-6 pathway.J Neurosci. 2013 Jul 10;33(28):11479-93. doi: 10.1523/JNEUROSCI.5566-12.2013. J Neurosci. 2013. PMID: 23843519 Free PMC article.
-
TLR4 enhances histamine-mediated pruritus by potentiating TRPV1 activity.Mol Brain. 2014 Aug 21;7:59. doi: 10.1186/s13041-014-0059-9. Mol Brain. 2014. PMID: 25139109 Free PMC article.
References
-
- Syed TA. A review of the applications of imiquimod: a novel immune response modifier. Expert opinion on pharmacotherapy. 2001;2(5):877–882. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources